4DN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Denali Therapeutics Inc

Watchlist Manager

Watchlist

Price: 21.74 EUR 2.35% Market Closed

Market Cap: €3.1B

D	Denali Therapeutics Inc F:4DN	US
S	Silk Road Medical Inc F:2OW	US
	S&U PLC F:97V	UK
E	Erotik Abwicklungsgesellschaft AG XHAM:USE	DE
	Medivir AB F:MVR	SE
N	Nova Ltd F:NMR	IL
C	Chigo Holding Ltd F:63C	HK

Profitability Summary

Denali Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Sustainable 3Y Average Gross Margin

19%

Negative Operating Margin

-15.058%

Negative 3Y Average Operating Margin

-10.673%

Declining Operating Margin

-48% > -15.058%

Negative Net Margin

-14.191%

Negative 3Y Average Net Margin

-9.320%

Declining Net Margin

-37% > -14.191%

Negative Free Cash Flow Margin

-12.937%

Negative 3Y Average Free Cash Flow Margin

-8.848%

Declining Free Cash Flow Margin

-94% > -12.937%

Negative ROE

-55%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-134%

Declining ROIC

-101% > -157%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.